Ampcera has an exclusive licensing agreement with PNNL to commercially develop and license a new battery material for applications such as vehicles and personal electronics.
Armed with some of the world’s most advanced instrumentation, researchers at PNNL are working to analyze huge amounts of data and uncover hidden biological connections.
PNNL biodefense experts seek to identify, understand and mitigate the risks of biological pathogens—whether naturally occurring or intentionally created—so steps can be taken to prepare and respond.
Research at PNNL and the University of Texas at El Paso are addressing computational challenges of thinking beyond the list and developing bioagent-agnostic signatures to assess threats.
Clean hydrogen energy infrastructure is coming to the Pacific Northwest with a newly announced hydrogen hub, and PNNL experts are advising the work to come.
At the Nonproliferation, Counterproliferation, and Disarmament Science Gordon Research Conference, researchers from PNNL shared research and scientific approaches for countering diverse threats.
PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.
Steven Spurgeon’s research is featured in the cover of the MRS Bulletin along with his team’s invited perspective on the future of machine learning for electron and scanning probe microscopy.
Johannes Lercher, Battelle Fellow and director of the PNNL Institute for Integrated Catalysis, envisions energy storage solutions at the new Energy Sciences Center.
A research team is exploring the safety and feasibility of clean hydrogen to replace some fossil fuel in medium- and heavy-duty vehicles and maritime uses at the Port of Seattle.
